Skip to main content

Table 3 Trend in the administration of tranexamic acid over time.

From: The impact of administration of tranexamic acid in reducing the use of red blood cells and other blood products in cardiac surgery

  

Number of patients (n = 4191)

Audit

Time frame

Total (%)

TA group (%)

NTA group (%)

1

30/10/00 – 18/02/01

348 (8)

247 (71)

101 (29)

2

23/04/01 – 02/09/01

413 (10)

277 (67)

136 (33)

3

12/11/01 – 20/12/02

1345 (32)

1139 (85)

206 (15)

4

20/01/03 – 31/12/03

1136 (27)

951 (84)

185 (16)

5

01/01/04 – 21/09/04

949(23)

745 (78)

204 (22)

  1. Trend in the administration of tranexamic acid over time. Implementation of new antifibrinolytic guidelines resulted in an overall increase in the number of patients receiving tranexamic acid (p < 0.001, Chi-Square test, significant). (TA – tranexamic acid, NTA – no tranexamic acid)